QuantRx Biomedical Corporation
QTXB · OTC
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Market Cap | $787 | $472 | $291 | $181 |
| - Cash | $6 | $55 | $130 | $322 |
| + Debt | $2,637 | $2,420 | $2,203 | $2,006 |
| Enterprise Value | $3,418 | $2,837 | $2,364 | $1,865 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | $0 | -$36 | -$202 | -$225 |
| % Margin | – | – | – | – |
| Net Income | -$477 | -$469 | -$820 | -$737 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.006 | -0.006 | -0.01 | -0.009 |
| % Growth | -1.7% | 42.3% | -10.6% | – |
| Operating Cash Flow | -$49 | -$75 | -$192 | -$258 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$49 | -$75 | -$192 | -$258 |